Surrozen, Inc./DE

SRZN Nasdaq CIK: 0001824893

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO, CA, 94080
Mailing Address 171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO, CA, 94080
Phone 650-475-2820
Fiscal Year End 1231
EIN 301374889

Financial Overview

FY2024

-$43.04M
Net Income
$48.47M
Total Assets
$36.04M
Cash & Equivalents

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report February 13, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 13, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 5, 2026 View on SEC
4 Insider stock transaction report February 3, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 2, 2026 View on SEC
8-K Current report of material events January 30, 2026 View on SEC
3 Initial insider ownership report January 28, 2026 View on SEC
4 Insider stock transaction report January 26, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment January 22, 2026 View on SEC
4 Insider stock transaction report January 20, 2026 View on SEC

Insider Trading

STRONG BUY 5 insiders 46 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.